Development and validation of a nomogram incorporating the 31-GEP test and clinicopathologic factors for accurate prediction of recurrence risk in patients with cutaneous melanoma

Main Article Content

R Thorpe
Ada West Dermatology

HG Caruso
Castle Biosciences, Inc.

KR Covington
Castle Biosciences, Inc.

D Brodland
Zitelli and Brodland, P.C.

J Zitelli
Zitelli and Brodland, P.C.

Keywords

GEP, cutaneous melanoma

Abstract

Abstract not available.

References

1.Geramiet al. Clin Cancer Res. 2015 Jan 1;21(1):175-83.
2.Geramiet al. JAAD. 2015 May;72(5):780-5.e3.
3.Zager et al. BMC Cancer. 2018 Feb 5;18(1):130.
4.Gastmanet al. JAAD. 2019 Jan;80(1):149-157.e4.
5.Hsueh et al. J HematolOncol. 2017 Aug 29;10(1):152.
6.Greenhawet al. Dermatol Surg. 2018 Dec;44(12):1494-1500.
7.Keller et al. Cancer Med. 2019 May;8(5):2205-2212.

Article Sidebar

Poster PDF
Published
Jan 28, 2020

Article Details

How to Cite
[1]
Thorpe, R., Caruso, H., Covington, K., Brodland, D. and Zitelli, J. 2020. Development and validation of a nomogram incorporating the 31-GEP test and clinicopathologic factors for accurate prediction of recurrence risk in patients with cutaneous melanoma. SKIN The Journal of Cutaneous Medicine. 4, 1 (Jan. 2020), S21.
Issue
Vol. 4 No. 1 (2020): January Issue & Poster Presentations (2020 Winter Clinical Dermatology Conference®)
Section
Skin Cancer
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.